ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE

Pre-Launch

abacavir, dolutegravir, lamivudine

Cipla
ANDATABLET
Lifecycle
Pre-Launch

Mechanism of Action

fixed-dose combination of the HIV‑1 antiretroviral agents abacavir, dolutegravir, and lamivudine [see Microbiology ()].

Indications (2)

HIV-1 infection in adultsweighing at least 6 kg
Company
Cipla
Cipla
India - Mumbai
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers